Management
Leadership Team
Mithun Patil
Managing Director &
Chief Executive Officer (CEO)
Dr. Avinash Mane
Director — Technical
Ph.D. Organic Chemistry
Saumya Bhatt
Director &
Chief Business Officer (CBO)
Kunal Mehta
Director
Doing Chemistry Differently
Manufacturing and supplying high-quality Specialty Chemicals, Intermediates, and RSMs of APIs to domestic and global Biopharma/Pharmaceutical sectors.
About the Group
Altra Group manufactures and supplies high-quality Specialty Chemicals, Intermediates, and Regulatory Starting Materials (RSMs) of the Active Pharmaceutical Ingredients (APIs) to domestic and global Biopharma/Pharmaceutical sectors. Our focus is on manufacturing high-end products involving complex Chemistries.
Our in-house state-of-the-art R&D Centre ensures innovation, precision, and compliance. We build lasting partnerships through customer-centric solutions.
As a part of CDMO/CRO activity, ALTRA supports Tier-1 companies in India and globally by manufacturing and supplying 'make to order' products with a dedicated technical team.
"We manufacture and supply high-quality intermediates of Active Pharmaceutical Ingredients globally. Our commitment is to become a trusted partner in the industry."
"We ensure safety and quality of the products manufactured at Altra in line with Altra's QMS policy by maintaining the highest standards, batch to batch consistency, purity and compliance."
Business Entities
An ISO 9001:2015 certified organization specializing in intermediates, RSMs, and specialty chemicals for global pharma/biopharma. Supports Tier-1 companies through CDMO/CRO services with dedicated R&D, Manufacturing, QC, and QA teams.
ISO 9001:2015 certified manufacturer of agrochemicals and intermediates. State-of-the-art facility in Ambarnath with advanced technologies and robust safety practices.
A leading manufacturer and supplier of industrial solvents at commercial scale in Maharashtra and Gujarat. Advanced distillation facilities meeting the highest purity benchmarks.
Dedicated organic chemistry division expanding capabilities across specialty organics and novel chemical synthesis for emerging fine chemicals markets.
Direction & Purpose
"To become a global leader in reshaping pharmaceutical and agriculture-innovation, delivering cutting-edge products in greener, smarter and more inclusive ways for a better tomorrow."
"To be a trusted partner in Pharma, Biopharma, Agrochemical, and Specialty Chemical Sectors by delivering sustainable and scientifically driven innovations that ensure reliability and confidence."
What Drives Us
Targeting sustainable double-digit growth by expanding market presence, launching eco-friendly products, and becoming a global leader by 2035.
Think like scientists, act like entrepreneurs. Data-backed decision-making from lab trials to commercialization.
Flexible and resilient manufacturing from pilot to commercial scale. Adapting to supply disruptions and regulatory challenges.
Highest quality, eco-friendly products with uncompromising safety, integrity, and environmental responsibility.
On-time, consistent quality. Multi-tier distribution with moisture-proof, UV-protected packaging and temperature-controlled transport.
Aligned with business goals, capital needs, risk appetite, and regulatory compliance at every level.
Our History
Management
Managing Director &
Chief Executive Officer (CEO)
Director — Technical
Ph.D. Organic Chemistry
Director &
Chief Business Officer (CBO)
Director
Product Portfolio
Comprehensive range of high-purity chemical intermediates for pharmaceutical and agrochemical manufacturing.
| # | Product Name | CAS No. | API |
|---|---|---|---|
| 1 | Methyl 6-methylnicotinate (M6MN) | 5470-70-2 | Etoricoxib |
| 2 | 1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone | 221615-75-4 | Etoricoxib |
| 3 | 4-(Methylsulfonyl)phenylacetic acid (MSP) | 90536-66-6 | Etoricoxib |
| 4 | 4-(Methylthio)benzeneacetonitrile (MTBC) | 38746-92-8 | Etoricoxib |
| 5 | 2-Chloro-1,3 bis(dimethylamino) trimethinium hexafluorophosphate | 249561-98-6 | Etoricoxib |
| 6 | 6-Methylnicotinic acid (6MNA) | 3222-47-7 | Etoricoxib |
| 7 | 2-Chloro-6-methylbenzoic acid (CMBA) | 21327-86-6 | Duvelisib |
| 8 | 3-(2-Chloroethyl)-2-methyl-9-(phenylmethoxy)-4H-pyrido[1,2-a]pyrimidin-4-one | 147687-17-0 | Paliperidone |
| 9 | 3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one | 130049-82-0 | Paliperidone |
| 10 | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid | 116118-98-0 | Edoxaban |
| 11 | Ethyl [(5-chloropyridin-2-yl)amino](oxo)acetate | 349125-08-2 | Edoxaban |
| 12 | 1-(2-Pyrimidinyl)piperazine | 20980-22-7 | Buspirone |
| 13 | 2-[4-(4-Bromobutyl)-1-piperazinyl]pyrimidine | 87789-48-8 | Buspirone |
| 14 | [(3S)-3-amino-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid | 88372-47-8 | Benazepril |
| 15 | 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl Methanesulfonate | 160969-03-9 | Silodosin |
| 16 | 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile | 239463-85-5 | Silodosin |
| 17 | 1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-(2-nitropropyl)-1H-indole-7-carbonitrile | 350797-56-7 | Silodosin |
| 18 | 1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-(2-oxopropyl)-1H-indole-7-carbonitrile | 350797-57-8 | Silodosin |
| 19 | 2-(2,2,2-Trifluoroethoxy)phenol | 160968-99-0 | Silodosin |
| 20 | 2-(4-Nitrophenyl) butyric acid (NPBA) | 7463-53-8 | Indobufen |
| 21 | 2,3-Xylidine | 87-59-2 | Mefenamic Acid |
| 22 | 2-(Hydroxymethyl)-3-nitrobenzoic acid | 2385152-82-7 | Lenalidomide |
| 23 | Methyl 2-(hydroxymethyl)-3-nitrobenzoate | 1628915-10-5 | Lenalidomide |
| 24 | 3-Amino-2-(hydroxymethyl)benzoic acid | 1780762-90-4 | Lenalidomide |
| 25 | Methyl 3-amino-2-(hydroxymethyl)benzoate | 2091024-66-5 | Lenalidomide |
| 26 | 2,2,2-Trifluoro ethylamine | 753-90-2 | Afoxolaner / Fluralaner |
| 27 | 1-(3-Chloro-5-(trifluoromethyl)phenyl)-2,2,2-trifluoroethanone | 1125812-58-9 | Afoxolaner |
| 28 | 1-(3,5-Dichlorophenyl)-2,2,2-trifluoroethanone | 130336-16-2 | Fluralaner |
| 29 | 1-(3,4-Dimethylphenyl)hydrazine hydrochloride | 60481-51-8 | Eltrombopag |
| 30 | 4-Aminobenzamidine dihydrochloride | 2498-50-2 | Dabigatran |
| 31 | 3-[(3-Amino-4-methylamino-benzoyl)-pyridin-2-yl-amino]-propionic acid ethyl ester | 212322-56-0 | Dabigatran |
| 32 | Ethyl 3-((4-(methylamino)-3-nitrobenzoyl)(pyridin-2-yl)amino)propanoate | 429659-01-8 | Dabigatran |
| # | Product Name | CAS No. | AI |
|---|---|---|---|
| 1 | 3-Nitro-o-xylene (3-NOX) | 83-41-0 | Pesticides |
| 2 | 4-Nitro-o-xylene (4-NOX) | 99-51-4 | Pendimethalin |
| 3 | 3-Methyl-2-nitrobenzoic acid (MNBA) | 5437-38-7 | Chlorantraniliprole |
| 4 | 2-Amino-5-cyano-N,3-dimethylbenzamide | 890707-29-6 | Cyantraniliprole |
| 5 | 2-Amino-5-chloro-3-methylbenzoic acid | 20776-67-4 | Chlorantraniliprole |
| 6 | 2-Amino-5-chloro-N,3-dimethylbenzamide | 890707-28-5 | Chlorantraniliprole |
| 7 | 2,4-Xylidine | 95-68-1 | Pesticides |
| 8 | 3,4-Xylidine | 95-64-7 | Pesticides |
| 9 | 2,3-Xylidine | 87-59-2 | Pesticides |
| 10 | 3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxylic acid | 500011-86-9 | Chlorantraniliprole |
| 11 | 3-Nitrophthalic acid | 603-11-2 | Flubendiamide |
| 12 | 3-Nitrophthalic Anhydride | 641-70-3 | Flubendiamide |
| 13 | 3-Aminophthalic Acid | 5434-20-8 | Flubendiamide |
| 14 | 4-Aminoisobenzofuran-1,3-dione | 17395-99-2 | Flubendiamide |
Custom Manufacturing
ALTRA supports Tier-1 companies by manufacturing and supplying 'make to order' products with a dedicated technical team as per agreed timelines and quality.
Evaluating multiple synthetic routes for optimal yield and cost.
Refining processes for scalability, purity, and efficiency.
Seamless transition from lab to pilot to commercial production.
Rigorous QC testing at every stage ensuring regulatory compliance.
Facilities & Capabilities
State-of-the-art QC lab for regulatory standards and consistency requirements.
Transparency & Governance
Audited financial statements of Altra Group entities, reflecting our commitment to transparency and corporate governance.
CIN: U24100MH1995PTC087600 · W-31 Phase-II, MIDC, Dombivli (E)
CIN: U24100MH2019PTC327706 · Plot No. 45, MIDC Phase-II, Dombivli (E)
The financial statements presented on this page are audited and prepared in compliance with the Companies Act, 2013 and applicable Accounting Standards. These documents are provided for informational purposes only. For any queries regarding the financials, please contact info@altragroup.in.
Health, Safety & Environment
Giving Back
Sponsoring education for underprivileged children in the local community around our manufacturing facilities.
Tree plantation drives, waste reduction initiatives, and water conservation programs in partnership with local bodies.
Organizing health camps and providing medical support to communities near our operational areas.
Comprehensive employee welfare programs including skill development, safety training, and family support systems.
Get in Touch
W-31 Phase-II, MIDC, Manpada Road,
Dombivli (East), Thane,
Maharashtra — 421204
Email: info@altragroup.in
Phone: +91 98208 08184
Manufacturing: Ambernath MIDC, Thane — 421505